Astrana Health Inc. - Common Stock (ASTH)
Industrials › Services-Management Consulting Services
Price History
Feb 9, 2026 — Mar 25, 2026Investment Snapshot
- Trading 136% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 11.5% — below-average profitability
- Revenue growing at 56% annually
Astrana Health Inc. - Common Stock (ASTH) is a Industrials company operating in Services-Management Consulting Services, listed on the NASDAQ , with a market capitalisation of $1.3 billion . Key value metrics: P/E ratio 41.0, P/B ratio 1.48, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Astrana Health Inc. - Common Stock — Fundamental Analysis Summary
Astrana Health Inc. - Common Stock (ASTH) is currently trading 136% above its Graham Number of $10.16, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 41.0x.
On financial health, ASTH shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and modest return on equity of 11.5% (sector average: 5.5%), and manageable leverage with a debt-to-equity ratio of 0.70.
StockPik's composite Value Score for ASTH is 38/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ASTH reports a moderate gross margin of 21.5% (sector average: 24.7%) and a modest operating margin of 3.3%.
ASTH shows revenue growing at 56% year-over-year, with earnings declining at 48%.